Stan N Finkelstein
Overview
Explore the profile of Stan N Finkelstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foundational model aided automatic high-throughput drug screening using self-controlled cohort study
Xu S, Cobzaru R, Finkelstein S, Welsch R, Ng K, Middleton L
medRxiv
. 2024 Aug;
PMID: 39148849
Background: Developing medicine from scratch to governmental authorization and detecting adverse drug reactions (ADR) have barely been economical, expeditious, and risk-averse investments. The availability of large-scale observational healthcare databases and...
2.
Charpignon M, Vakulenko-Lagun B, Zheng B, Magdamo C, Su B, Evans K, et al.
Nat Commun
. 2022 Dec;
13(1):7652.
PMID: 36496454
Metformin, a diabetes drug with anti-aging cellular responses, has complex actions that may alter dementia onset. Mixed results are emerging from prior observational studies. To address this complexity, we deploy...
3.
Diniz P, Ferreira A, Figueiredo L, Batista J, Abdelatif N, Pereira H, et al.
Knee Surg Sports Traumatol Arthrosc
. 2022 Sep;
31(5):2001-2014.
PMID: 36149468
Purpose: Current options for treating an Achilles tendon rupture (ATR) include conservative and surgical approaches. Endoscopic flexor hallucis longus (FHL) transfer has been recently proposed to treat acute ruptures, but...
4.
Bandeiras C, Hwa A, Cabral J, Ferreira F, Finkelstein S, Gabbay R
Curr Diab Rep
. 2019 Aug;
19(9):75.
PMID: 31375935
Purpose Of Review: Type 1 diabetes impacts 1.3 million people in the USA with a total direct lifetime medical cost of $133.7 billion. Management requires a mix of daily exogenous...
5.
Bandeiras C, Cabral J, Gabbay R, Finkelstein S, Ferreira F
Biotechnol J
. 2019 May;
14(8):e1800563.
PMID: 31127682
Differentiation of pluripotent stem cells (PSCs) into β cells could provide insulin independence for type 1 diabetes (T1D) patients. This approach would reduce the clinical complications that most patients managed...
6.
Bandeiras C, Cabral J, Finkelstein S, Ferreira F
Regen Med
. 2018 Nov;
13(8):917-933.
PMID: 30488770
Aim: To evaluate the cost-effectiveness of autologous cell therapy manufacturing in xeno-free conditions. Materials & Methods: Published data on the isolation and expansion of mesenchymal stem/stromal cells introduced donor, multipassage...
7.
Majumder M, Brownstein J, Finkelstein S, Larson R, Bourouiba L
Trans R Soc Trop Med Hyg
. 2017 Oct;
111(6):261-269.
PMID: 29044371
Background: Nosocomial amplification resulted in nearly 200 cases of Middle East respiratory syndrome (MERS) during the 2015 South Korean MERS-coronavirus outbreak. It remains unclear whether certain types of cases were...
8.
Hashmi S, DAmbrosio L, Diamond D, Jalali M, Finkelstein S, Larson R
J Public Health (Oxf)
. 2017 Feb;
38(4):739-745.
PMID: 28158761
No abstract available.
9.
Krupat E, Dienstag J, Kester W, Finkelstein S
Eval Health Prof
. 2016 Jan;
40(2):203-218.
PMID: 26801747
Increasingly, health care is being delivered in large, complex organizations, and physicians must learn to function effectively in them. As a result, several medical and business schools have developed joint...
10.
Pereira R, Salgado C, Dejam A, Reti S, Vieira S, Sousa J, et al.
ScientificWorldJournal
. 2015 Sep;
2015:212703.
PMID: 26345130
Left ventricular ejection fraction (LVEF) constitutes an important physiological parameter for the assessment of cardiac function, particularly in the settings of coronary artery disease and heart failure. This study explores...